SCHEMBL28022149

SCHEMBL28022149

NCCOOB(c1ccccc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.64
MAPK1 P28482 2/20 0.64
HPGD P15428 2/20 0.64
MEN1 O00255 1/20 0.64
TRPM2 O94759 1/20 0.64
ALDH1A1 P00352 1/20 0.64
CYP1A2 P05177 1/20 0.64
CYP3A4 P08684 1/20 0.64
THRB P10828 1/20 0.64
ALOX15 P16050 1/20 0.64
TSHR P16473 1/20 0.64
ALOX12 P18054 1/20 0.64
KMT2A Q03164 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
ORAI1 Q96D31 1/20 0.44
ORAI2 Q96SN7 1/20 0.44
ORAI3 Q9BRQ5 1/20 0.44
TRPV6 Q9H1D0 1/20 0.44
TAAR1 Q96RJ0 2/20 0.43
KIF11 P52732 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL341835 0.78 KDM4E (1.00) KDM4EMAPK1HPGDMEN1TRPM2
SCHEMBL2412888 0.77 KDM4E (0.96) KDM4EMAPK1HPGDMEN1TRPM2
SCHEMBL28480364 0.76 KDM4E (0.46) KDM4EMAPK1HPGDMEN1TRPM2
SCHEMBL2410144 0.73 KDM4E (0.88) KDM4EMAPK1HPGDMEN1TRPM2
SCHEMBL12270752 0.73 KDM4E (0.81) KDM4EMAPK1HPGDMEN1TRPM2
SCHEMBL93572 0.72 TAAR1 (0.50) KDM4EMAPK1HPGDMEN1TRPM2
SCHEMBL2409329 0.72 KDM4E (0.85) KDM4EMAPK1HPGDMEN1TRPM2
SCHEMBL12266145 0.69 CYP1A2 (0.79) KDM4EMAPK1HPGDMEN1TRPM2
SCHEMBL14198827 0.69 KDM4E (0.79) KDM4EMAPK1HPGDMEN1TRPM2
SCHEMBL12266286 0.69 KDM4E (0.72) KDM4EMAPK1HPGDMEN1TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113692304-A 1- ((2- (2,2, 2-trifluoroethoxy) pyridin-4-yl) methyl) urea derivatives as KCNQ enhancers 礼来公司 2021-11-23 CN disclosed
CN-104203256-B Therapeutic alliance for the glucosaminoglycan comprising sulphation of induced labor 迪乐方有限责任公司 2017-11-24 CN disclosed
CN-104244957-B The method stopped for treating childbirth 迪乐方有限责任公司 2017-11-17 CN disclosed
CN-105579044-A Use of dianhydrogalactitol and analogs and derivatives thereof for treating recurrent malignant glioma or progressive secondary brain tumor DEL MAR PHARMACEUTICALS 2016-05-11 CN disclosed
CN-105492011-A Therapeutic synergy of undesirable chemical compounds BROWN DENNIS M 2016-04-13 CN disclosed
CN-104797267-A Method of treating tyrosine kinase inhibitor-resistant malignancies in patients with genetic polymorphism or AHI1 dysregulation or mutation using dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof DEL MAR PHARMACEUTICALS 2015-07-22 CN disclosed